- Filed
- Dec 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 252.05M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 260.27M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 261.97M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 275.11M sh |
| Stock Repurchased | Q3 2026 · Oct 31, 2025 | $152.26M |
| Stock Repurchased | Q3 2026 · Oct 31, 2024 | $273.87M |
| Capex | Q3 2026 · Oct 31, 2025 | $839K |
| Capex | Q3 2026 · Oct 31, 2024 | $5M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | $138.53M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | $72.23M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $189.59M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $145.27M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $558.09M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $543.44M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $612.06M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $497.02M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $468.97M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | $679.7M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $444.06M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $517.58M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $495.8M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $572.14M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $735.64M |
| Current Assets | Q3 2026 · Jan 31, 2025 | $854.1M |
| Total Assets | Q3 2026 · Oct 31, 2025 | $1.05B |
| Total Assets | Q3 2026 · Jan 31, 2025 | $1.18B |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.01 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | $0.05 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.04 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.08 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | $0.01 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | $0.06 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | $0.04 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | $0.09 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $33.69M |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $103.69M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $34.12M |
| Sga Expense restated | Q3 2026 · Oct 31, 2024 | $102.01M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $24.71M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $70.68M |
| Rd Expense restated | Q3 2026 · Oct 31, 2024 | $23.3M |
| Rd Expense restated | Q3 2026 · Oct 31, 2024 | $69.06M |
| Net Income | Q3 2026 · Oct 31, 2025 | $2.9M |
| Net Income | Q3 2026 · Oct 31, 2025 | $13.95M |
| Net Income | Q3 2026 · Oct 31, 2024 | $10.46M |
| Net Income | Q3 2026 · Oct 31, 2024 | $22.93M |
| Operating Income | Q3 2026 · Oct 31, 2025 | $11.55M |
| Operating Income | Q3 2026 · Oct 31, 2025 | $26.07M |
| Operating Income | Q3 2026 · Oct 31, 2024 | $7.89M |
| Operating Income | Q3 2026 · Oct 31, 2024 | $13.51M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $145.49M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $432.96M |
| Gross Profit restated | Q3 2026 · Oct 31, 2024 | $142.84M |
| Gross Profit restated | Q3 2026 · Oct 31, 2024 | $430.91M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $73.58M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $203.65M |
| Cost Of Revenue restated | Q3 2026 · Oct 31, 2024 | $57.85M |
| Cost Of Revenue restated | Q3 2026 · Oct 31, 2024 | $162.94M |
| Revenue | Q3 2026 · Oct 31, 2025 | $219.07M |
| Revenue | Q3 2026 · Oct 31, 2025 | $636.61M |
| Revenue | Q3 2026 · Oct 31, 2024 | $200.69M |
| Revenue | Q3 2026 · Oct 31, 2024 | $593.86M |